We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UDR icon
801
UDR
UDR
$12.7B
– –
-7,763
Closed -$290K
VTRS icon
802
Viatris
VTRS
$20.8B
– –
-50
Closed -$1K
TPC
803
Tutor Perini Cor
TPC
$4.31B
– –
-17,000
Closed -$207K
RVNC
804
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-45,000
Closed -$1.1M
GTHX
805
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-870,423
Closed -$21.1M
BLU
806
DELISTED
BELLUS Health Inc.
BLU
– –
-382,013
Closed -$3.93M
TCDA
807
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-191,500
Closed -$5.26M
TWTR
808
CALL
DELISTED
Twitter, Inc.
TWTR
– –
-12,541,400
Closed -$3.74M
GBT
809
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-67,843
Closed -$4.28M
FPRX
810
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-502,177
Closed -$3.06M
PRNB
811
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
– –
-41,658
Closed -$2.49M
LOGM
812
DELISTED
LogMein, Inc.
LOGM
– –
-54,213
Closed -$4.6M
LM
813
DELISTED
Legg Mason, Inc.
LM
– –
-183,184
Closed -$9.11M
TMUSR
814
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
– –
-29,258
Closed -$5K
PTLA
815
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-256,198
Closed -$6.09M
MINI
816
DELISTED
Mobile Mini Inc
MINI
– –
-58,778
Closed -$1.74M
IBKC
817
DELISTED
IBERIABANK Corp
IBKC
– –
-374,285
Closed -$17M
TECD
818
DELISTED
Tech Data Corp
TECD
– –
-68,489
Closed -$9.93M
MEET
819
DELISTED
The Meet Group, Inc. Common Stock
MEET
– –
-2,677,137
Closed -$16.7M
DISH
820
DELISTED
DISH Network Corp.
DISH
– –
-14,135
Closed -$488K
CHL
821
DELISTED
China Mobile Limited
CHL
– –
-56,126
Closed -$1.89M
EE
822
DELISTED
El Paso Electric Company
EE
– –
-219,615
Closed -$14.7M
VG
823
PUT
DELISTED
Vonage Holdings Corporation
VG
– –
-5,614,000
Closed -$915K
29 30 31 32
33

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.